Zhong, Qiaofeng
Chen, Haizhu
Chen, Daoguang
Qin, Yan
He, Xiaohui
Yang, Yu
Yang, Jianliang
Liu, Peng
Zhou, Shengyu
Yang, Sheng
Zhou, Yu
Tang, Le
Chen, Chuanben
Shi, Yuankai http://orcid.org/0000-0002-3342-4964
Funding for this research was provided by:
China National Major Project for New Drug Innovation (2017ZX09304015)
Scientific Research Foundation of Fujian Cancer Hospital (2021YNY02)
Natural Science Foundation of Fujian Province (2023J05241)
Postdoctoral Research Foundation of China (2023M734015)
Article History
Received: 3 February 2023
Accepted: 30 September 2023
First Online: 20 October 2023
Declarations
:
: This study was performed in accordance with the Declaration of Helsinki and approved by the Institutional Review Board of Cancer Hospital, Chinese Academy of Medical Sciences (No. NCC2018JJJ-004) and Fujian Cancer Hospital (No. SQ2022-090–01).
: The authors declare no competing interests.
: Informed consent was waived due to the retrospective nature of the present study, and data of the participants have been anonymized.